DON'T FORGET THE WINE Trademark

Trademark Overview


On Wednesday, February 27, 2002, a trademark application was filed for DON'T FORGET THE WINE with the United States Patent and Trademark Office. The USPTO has given the DON'T FORGET THE WINE trademark a serial number of 76375789. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Monday, March 31, 2003. This trademark is owned by Chateau Diana LLC. The DON'T FORGET THE WINE trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Wines & Spirits categories with the following description:

Information processing devices, namely computer keyboards, mouse, monitors, readers, data processing equipment, compact disc players, optical character readers, computer memories, printers for use with computers, processors; computer programs and software for stockage, management, and analysis of biological information

Biological reagents for diagnoses and for identification of biological systems; pharmaceutical products, namely preparations, chemical preparations and chemico-pharmaceutical preparations for treating illnesses, namely genetic and infectious illnesses namely, acute leukemia, acute lymphoblastic leukemia, acute myelogenous leukemia AML, acute monocytic leukemia, AML, acute promyelocytic leukemia, APL, adenocarcinoma, adenocarcinoma lung cancer, adenocystic carcinoma, adenoid cystic breast cancer, adenoid cystic arcinoma, adrenal gland cancer, advanced breast cancer, aggressive breast cancer, ameloblastoma, anal, anus cancer; angiosarcoma, appendix cancer, appendiceal cancer, astrocytoma, arrett's esophagus, bartholin gland cancer, basal cell carcinoma, basal cell skin cancer, B-cell lymphoma, bilateral breast cancer, bile ductcancer, bladder *cancer, bladder metastases, bone cancer, bone marrow transplantation, Bowen's disease, bone metastases, borderline ovarian cancer, brain metastase...
don't forget the wine

General Information


Serial Number76375789
Word MarkDON'T FORGET THE WINE
Filing DateWednesday, February 27, 2002
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateMonday, March 31, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 27, 2002

Trademark Statements


Goods and ServicesInformation processing devices, namely computer keyboards, mouse, monitors, readers, data processing equipment, compact disc players, optical character readers, computer memories, printers for use with computers, processors; computer programs and software for stockage, management, and analysis of biological information
Goods and ServicesBiological reagents for diagnoses and for identification of biological systems; pharmaceutical products, namely preparations, chemical preparations and chemico-pharmaceutical preparations for treating illnesses, namely genetic and infectious illnesses namely, acute leukemia, acute lymphoblastic leukemia, acute myelogenous leukemia AML, acute monocytic leukemia, AML, acute promyelocytic leukemia, APL, adenocarcinoma, adenocarcinoma lung cancer, adenocystic carcinoma, adenoid cystic breast cancer, adenoid cystic arcinoma, adrenal gland cancer, advanced breast cancer, aggressive breast cancer, ameloblastoma, anal, anus cancer; angiosarcoma, appendix cancer, appendiceal cancer, astrocytoma, arrett's esophagus, bartholin gland cancer, basal cell carcinoma, basal cell skin cancer, B-cell lymphoma, bilateral breast cancer, bile ductcancer, bladder *cancer, bladder metastases, bone cancer, bone marrow transplantation, Bowen's disease, bone metastases, borderline ovarian cancer, brain metastases, brain tumor, brainstem glioma, breast cancer, breast reconstruction, bronchial cancer, bronchioalveolar lung cancer, buttock cancer, cancer of unknown primary site, CUPS , cancer prevention, carcinoma of unknown primary, carcinoid, carcinoid syndrome, carcinoid tumor, carcmosarcoma, cavernous sinus cancer, cecum cancer, central nervous system lymphoma,centrocytic lymphoma, cerebral astrocytoma, cervix cancer, cervical cancer, chest tumors, mediastinum tumors, chiasmal glioma, childhood cancers, chondroma, intracranial, chordoma, chondrosarcoma, chorioadenoma destruens, choroids plexus carcinoma, choroidal melanoma, chronic leukemia, chronic lymphocytic leukemia, CLL, chronic myelogenous leukemia, CML, clear cell ovarian cancer, clear cell sarcoma, CNS lymphoma, colon cancer, adenocarcinoma of the colon, adenomatous polyps, polyps, colorectal cancer, craniopharyngioma, cutaneous T-cell lymphoma, DCIS - ductal carcinoma in situ, dermatofibrosarcoma protuberans, desmoidtumor, desmoplastic tumor, diffuse lymphoma, diffuse, large-cell lymphoma, ductal carcinoma in situ, DCIS, duodenalcancer dysgerminoma, early stage prostate cancer, endocrine cancer, endometrial cancer, endometrial stromal sarcoma, ependymoma, esophagus cancer, esophageal cancer, esophagus cancer of the gastro esophageal junction, esthesioneuroblastoma, Ewing's sarcoma, extensive stage small cell lung cancer, extrahepatic bile duct cancer, extraskeletal chondrosarcoma, extraskeletal Ewing's sarcoma, extraskeletal osteosarcoma, eyemetastases, eye cancer, fallopian tube cancer, fibrosarcoma, fibrous histiocytoma, follicular lymphoma, follicular, small-cleaved cell lymphoma, gallbladder cancer, gastric cancer, gastnnoma, gastro-esophageal, GE junction, cancer, gastrointestinal lymphoma, GE junction esophageal cancer, germ cell tumor, gestational trophoblastic disease, giant cell bone tumor, glioblastoma, glioma, gliomatosis, granular lymphocytic lymphoma, granulocytic leukemia, granulosa cell ovarian cancer, hairy cell leukemia, heed and neck cancer, hemangioendothelioma, hemangiopericytoma, hepatocelluar carcinoma, high-gradelymphoma, high-risk breast cancer, histiocytoma, malignant, Hodgkin's disease, Hodgkin's disease in pregnancy, hormone-refractory prostate cancer, in situ breast cancer, insulinoma, intermediate-grade lymphoma, intraocular melanoma, invasive lobular breast cancer, islet cell pancreatic cancer, Kaposi's sarcoma, kidney cancer, krukenberg tumor, large-cell lung cancer, large-cell lymphoma, large-cell, diffuse lymphoma, larynx cancer, laryngeal cancer, leiomyosarcoma, lentigo maligna, leukemia, linitis plastica, limited stage small cell lung cancer, lip cancer, liposarcoma, liver cancer, recurrent liver cancer, undifferentiated liver cancer, lobular carcinoma in situ, LCIS, lobular hyperplasia low-grade lymphoma, lung cancer, non-small cell lung cancer, epidermoid carcinoma, large cell carcinoma, squamous cell carcinoma, spindal cell variant, pancoast tumors, superior sSulcus tumors, undifferentiated carcinoma, lung metastases, lymph node excision, lymphangitic metastasis, lymph node metastases, lymphoblastic leukemia, lymphoblastic lymphoma, lymphocytic lymphoma, lymphoma, non-Hodgkin's lymphoma, malignant ascites, malignant hemangiopericytoma, malignant fibrous histiocytoma, malignant peripheral nerve sheath tumor, malignant pleural effusion, malignant schwannoma, MALT lymphoma, mantle cell lymphoma, medlastinal tumor, medulloblastoma, melanoma, meningeal cancer meningeal metastases, meningioma, merkel cell carcinoma, merkel cell skin cancer, mesothelioma, mesenchymal chondrosarcoma, metastatic melanoma, mixed mullerian tumor, mucinous carcinoma, multiple myeloma, muscle-invasive bladder tumor, mycosis fungoides, myelodysplasia, myelodysplastic syndrome, myeloma, Bence-Jones, myeloproliferative disorder, nail/nail bed cancer, nasal cavity cancer, nasopharynx cancer, neck, radical dissection, neoplastic meningitis, nerve sheath tumors, neuroblastoma, neuroendocrine tumor, adenosquamous carcinoma, adenocarcinoma, ocular melanoma, olfactory cancer, oligodendroglioma, optic glioma, oral cancer, orbital lumphoma,orophaiynx cancer, osteogenic sarcoma, osteosarcoma, ovarian cancer, Pagets disease of the breast, pancreatic cancer, recurrent pancreatic cancer, borderline pancreatic tumors, mucinous cystic tumor with dysplasia, intraductal papillary mucinous tumor with dysplasia, pseudopapillary solid tumor, islet cell tumors, gastrinoma, paraganglioma, paranasal sinus cancer, paraneoplastic syndromes, parathyroid cancer, parotid gland cancer, pelvic tumor, penis cancer, periampullary cancer, pericardial effusion, peripheral nerve sheath tumor, peripheral T-cell lymphoma, peritoneal cancer, extraovarian serous carcinoma, extraovarianperitoneal serious papillary carcinoma, serous surface carcinoma of the peritoneum, serous surface papillary carcinoma, papillary serous carcinoma of the peritoneum, multiple focal peritoneal papillary carcinoma, primary peritoneal papillary serous adenocarcinoma, peritoneal carcinomatosis, pheochromocytoma, pinealoma, pineoblastoma, plasmacytoma, pleura cancer, pleura metastases, preleukemia, primary central nervous system lymphoma, primitive neuroctodermal tumor, PNET, plolymphocytic leukemia, promyelocytic PiN, PSA, pseudomyxoma peritonei, rectal cancer, recurrent colon cancer, recurrent colorectal cancer, recurrent lung cancer, recurrent melanoma, recurrent ovarian cancer, recurrent prostate cancer, recurrent rectal cancer, relapsed lymphoma, renal cell carcinoma, renal pelvis cancer, retinoblastoma, rhabdomyosarcoma, Richters syndrome, rising PSA as an indication of recurrent prostate cancer, salivary gland cancer, sarcoma of bone,sarcomatoid carcinoma; sebaceous carcinoma, sezary syndrome, sinus, cavernous, sinus cancer, skin cancer, skin metastases, small cell bladder cancer, small cell lung cancer, small cleaved cell lymphoma, small intestine cancer, soft tissue lymphoma, soft tissue sarcoma, synovial sarcoma, spinal cord cancer, spindle cell thyroid cancer, squamous cell cancer, non-skin, squamous cell lung cancer, squamous cell skin cancer, stem cell transplantation, stomach cancer, superficial bladder cancer, sweat glands cancer, T-cell leukemia, T-celllymphoma, cutaneous, testicular cancer, testis cancer, thalamu, thalamic, brain tumor, thymoma, thymus gland cancer, thyroid cancer, thyroid lymphoma, tongue cancer, tongue base cancer, transitional cell cancer of renal pelvis, transitional cell cancer of the ureter, unknown primary cancer, ureter cancer, urethra cancer, uterine cancer, uterine sarcoma, vagina cancer, vocal cord cancer, vulva cancer, Waldenstrom's macroglobulinemia,Warthin's tumor, Wilms' tumor, Zollinger-Ellis syndrome
Pseudo MarkDO NOT FORGET THE WINE

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateThursday, October 7, 2004
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class033 - Alcoholic beverages (except beers).
US Class Codes047, 049
Class Status Code8 - Abandoned
Class Status DateMonday, March 31, 2003
Primary Code033
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameChateau Diana LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHealdsburg, CA 95448

Party NameChateau Diana LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHealdsburg, CA 95448

Trademark Events


Event DateEvent Description
Monday, March 31, 2003ABANDONMENT - AFTER INTER PARTES DECISION
Monday, March 31, 2003OPPOSITION TERMINATED NO. 999999
Monday, March 31, 2003OPPOSITION SUSTAINED NO. 999999
Wednesday, November 20, 2002OPPOSITION INSTITUTED NO. 999999
Monday, September 23, 2002OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, August 27, 2002PUBLISHED FOR OPPOSITION
Wednesday, August 7, 2002NOTICE OF PUBLICATION
Thursday, May 30, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 23, 2002ASSIGNED TO EXAMINER